PMID- 10610716 OWN - NLM STAT- MEDLINE DCOM- 20000209 LR - 20141120 IS - 0888-7543 (Print) IS - 0888-7543 (Linking) VI - 62 IP - 2 DP - 1999 Dec 1 TI - The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression. PG - 223-31 AB - Acid ceramidase (AC) is the lysosomal enzyme that degrades ceramide into sphingosine and fatty acid. A deficiency in human AC activity leads to the lysosomal storage disorder, Farber disease (FD). The human AC gene (HGMW-approved symbol ASAH) was cloned and characterized, revealing an organization similar to that of the murine AC gene. The human gene spans about 30 kb in length and contains 14 exons ranging in size from 46 to 1201 bp. The exon/intron junctions were determined and found to follow the GT-AG rule. The putative promoter region had a GC content over 60%, lacked a TATA box, and contained several sequences matching transcription factor binding sites, including nine SP-1 sites, one AP-1 site, and three CACC boxes. The promoter activity of a 475-bp fragment from within this region was demonstrated by chloramphenicol acyltransferase assays. Northern blotting revealed variable expression of the human AC RNA; i.e., expression of the major 2.4-kb transcript was high in heart and kidney, followed by lung and placenta, but low in pancreas, liver, brain, and skeletal muscle. Two minor AC transcripts of 1.7 and 1.2 kb also were detected in heart and skeletal muscle. The human AC gene was mapped to the chromosomal region 8p21.3-p22 by in situ hybridization and FISH analyses, syntenic with the mouse chromosomal location. Finally, three new missense mutations, E138V, R254G, and P362R, were identified in the human AC gene from FD patients. Mutant AC cDNAs containing these point mutations were constructed and examined using the FLAG-tagged expression system. Although the levels of protein expression for these mutant ACs were about equivalent to that of the controls, their enzymatic activity was markedly reduced, confirming their authenticity. CI - Copyright 1999 Academic Press. FAU - Li, C M AU - Li CM AD - Department of Human Genetics, Mount Sinai School of Medicine, New York 10029, USA. FAU - Park, J H AU - Park JH FAU - He, X AU - He X FAU - Levy, B AU - Levy B FAU - Chen, F AU - Chen F FAU - Arai, K AU - Arai K FAU - Adler, D A AU - Adler DA FAU - Disteche, C M AU - Disteche CM FAU - Koch, J AU - Koch J FAU - Sandhoff, K AU - Sandhoff K FAU - Schuchman, E H AU - Schuchman EH LA - eng GR - DK 54830/DK/NIDDK NIH HHS/United States GR - HD 28607/HD/NICHD NIH HHS/United States GR - RR 0071/RR/NCRR NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Genomics JT - Genomics JID - 8800135 RN - 0 (DNA, Complementary) RN - 0 (Oligopeptides) RN - 0 (Peptides) RN - 63231-63-0 (RNA) RN - 98849-88-8 (FLAG peptide) RN - EC 3.5.- (Amidohydrolases) RN - EC 3.5.1.23 (ASAH1 protein, human) RN - EC 3.5.1.23 (Acid Ceramidase) RN - EC 3.5.1.23 (Asah1 protein, mouse) RN - EC 3.5.1.23 (Ceramidases) SB - IM MH - 3T3 Cells MH - Acid Ceramidase MH - Amidohydrolases/biosynthesis/*chemistry/*genetics MH - Animals MH - Base Sequence MH - COS Cells MH - Ceramidases MH - Chromosomes, Human, Pair 8/*genetics MH - DNA Mutational Analysis MH - DNA, Complementary/biosynthesis MH - Gene Expression Regulation, Enzymologic MH - Humans MH - Lysosomal Storage Diseases/enzymology/genetics MH - Male MH - Mice MH - Molecular Sequence Data MH - Mutation, Missense MH - Oligopeptides MH - Organ Specificity/genetics MH - Peptides/genetics MH - RNA/biosynthesis EDAT- 1999/12/28 00:00 MHDA- 1999/12/28 00:01 CRDT- 1999/12/28 00:00 PHST- 1999/12/28 00:00 [pubmed] PHST- 1999/12/28 00:01 [medline] PHST- 1999/12/28 00:00 [entrez] AID - 10.1006/geno.1999.5940 [doi] AID - S0888-7543(99)95940-2 [pii] PST - ppublish SO - Genomics. 1999 Dec 1;62(2):223-31. doi: 10.1006/geno.1999.5940.